About Acipimox
Aggiornamento: 16 gennaio 2013
Acipimox: meccanismo d'azione
L'Acipimox Tissuta grassa libera e lipasi epatica lipoproteina. The consequence is a decrease in the rate of atherogenic lipoproteins (ldl, low-density lipoprotein and vldl, v ery-tra) dans le sang, et donc des Triglycerides and of cholesterol. At the same time, an increase in the Tasso di lipoproteine anti-erogeno (HDL,High-Density Lipoprotein).
L’efficacité de cette action dans la prévention des maladies cardiaques n’est pas démontrée.